daratumumab,belantamab mafodotin,carfilzomib,dexamethasone
janssen,amgen,gsk
#ims2022 | presents the interim analysis of belamaf + kd in the first 10 patients treated. despite the small numbers, investigators are encouraged by the responses seen in daratumumab and pi-exposed patients #mmsm 
The Multiple Myeloma (MM) Hub is an online educational resource run in collaboration with the European School of Haematology @ESHaematology #mmsm #myeloma